gettyimages

‘A huge amount of wasted effort’: Most COVID-19 studies too small to yield real results

Erin Riglin, Matthew Herper | 
1,200 clinical trials aimed at testing treatment and prevention strategies against Covid-19 [have been designed] since the start of January ...
ace

The human protein that might explain who’s most at risk from Covid-19

Megan Molteni | 
The earliest clinical data out of China showed that some [COVID-19 patients] consistently fared worse than others, notably men, the ...
asymptomatic transmission coronavirus pandemic graphic x

Who are COVID-19 ‘super spreaders’ and how do they transmit the virus so widely

Carl Zimmer | 
Growing evidence shows most infected people aren’t spreading the virus. But whether you become a superspreader probably depends more on ...
large

Podcast: Europe suspends GMO rules to speed COVID vaccine; genes and coronavirus; Keto diet fights Alzheimer’s?

Cameron English, Kevin Folta | 
Europe has suspended some of its oppressive GMO regulations to speed development of a COVID-19 vaccine, drawing accusations of hypocrisy ...
cancer a

In the race to develop a COVID-19 vaccine, ethical concerns abound

Bethany Brookshire | 
How do we ethically test it in people? Can people be forced to get the vaccine if they don’t want it? ...
people crowd masks colourful

The novel coronavirus is a random murderer

Six months into a pandemic that has killed more than 400,000 people globally, scientists are still trying to understand the ...
large

COVID-19 is causing silent epidemics — societal and medical crises

Henry Miller, Shiv Sharma | 
As the nation emerges in fits and starts from the lockdowns spurred by the first wave of COVID-19 illnesses, we’re ...
skynews herd immunity coronavirus

Early COVID-19 hotspots like New York City and northern Italy may be edging towards herd immunity

Allysia Finley | 
There are reasons to think the novel coronavirus began spreading earlier than previously understood, raising the possibility that herd immunity ...
common food additive may weaken flu vaccine as seen in mouse models

Genetic puzzle: How mice can be modified to help in the race to develop coronavirus therapies

William Hoffman | 
For more than three decades Michael Koob has been working out complicated puzzles using the tools of molecular biology and genetics ...
poor research hero

‘Desperation is not a strategy’: Slew of low quality studies clouds picture of how to confront COVID-19

Marilynn Marchione | 
Desperate to solve the deadly conundrum of COVID-19, the world is clamoring for fast answers and solutions from a research ...
ynews dna genome covid

In your genes? DNA holds clues about how you will fare when exposed to coronavirus

Josh Rappoport | 
Although the spread of SARS-CoV2, the virus causing COVID-19, has slowed in many places that have successfully “flattened the curve”, ...
vaccine

‘It’s not premature to plan’: Deciding who gets the coronavirus vaccine first

Jon Cohen | 
The new coronavirus’ disproportionate toll on the elderly could put them at the front of the line [for a vaccine] ...
european parliament

European Union suspends some GMO regulations to fast-track COVID-19 vaccine

Sylvester Phelan | 
The EU’s stance on genetically modified organisms (GMOs) has been criticized by the Consumer Choice Center, which has labelled it ...
unnamed file

Mystery inflammation syndrome connected to COVID-19 in children results in brain damage

Ed Cara | 
[Children with COVID-19] can suffer everything from headaches to muscle weakness, along with visible signs of damage to the brain ...
stock cloud sneeze c adapt

Japan tamed COVID-19 without lockdowns. Here’s how

Yasutoshi Nishimura | 
By following the science developed by world-renowned experts, Japan has been able to avoid the worst effects of the pandemic ...
unnamed file

Viewpoint: Telescoping coronavirus vaccine testing and approval timelines exposes all of us to unnecessary dangers

William Haseltine | 
We all hope for a rapid end to the pandemic and an effective vaccine would be a surefire solution. But ...
neanderthal hero l

Our Neanderthal DNA might explain who gets sickest from COVID-19

Ananya Mandal | 
[A] small fragment of the genetic code that has been inherited by modern humans from Neanderthals could carry the secret ...
coronavirus who does it affect

Who is most vulnerable by age and race to die from COVID-19?

Alex Berezow | 
While coronavirus is obviously concerning and a very real threat to some people (namely, the elderly and immunocompromised), these data ...
Viewpoint: How biotech crops, lab-grown meat and other food innovations could jump start post-COVID economic recovery

Viewpoint: How biotech crops, lab-grown meat and other food innovations could jump start post-COVID economic recovery

Dan Rejto | 
COVID-19 threatens to slow or halt agricultural innovation in the US by exacerbating the decline in public R&D and threatening ...
screen shot at pm

Structural discrimination: COVID-19 illuminates healthcare inequalities for blacks

Meghana Keshavan | 
The disparities have long been documented. Black people are more likely than white people to die from cancer. They are ...
herd immunity threshold could be lower according to new study x

Infographic: COVID-19 herd immunity threshold likely varies from region to region

Kevin Hartnett | 
[A] lot of nuance is involved in calculating exactly how much of the population needs to be immune [to COVID-19] ...
cells infected with sars cov

‘Zombie cells’ infected with coronavirus sprout ‘ghoulish’ tentacles that reach out and hijack neighbors

Melissa Healy | 
Researchers exploring the interaction between the coronavirus and its hosts have discovered that when the SARS-CoV-2 virus infects a human ...
unnamed file

Cytokine storms: This doctor hunting down a COVID-19 treatment the same way he cured his own rare disease

Ryan Prior | 
35-year-old associate professor at the University of Pennsylvania Perelman School of Medicine [David Fajgenbaum] leads the school's Center for Cytokine ...
bxorbfaw a

Big risk, big rewards: Betting on RNA to make cheaper, faster coronavirus vaccines

Carolyn Johnson, William Booth | 
[A] promising — but unproven — new generation of vaccine technologies is based on deploying a tiny snip of genetic ...
vaccine prices

Crisis on the horizon? Nothing limits virus vaccine makers from charging exorbitant fees

Elisabeth Rosenthal | 
[A] Covid-19 vaccine will have an actual price tag. And given the prevailing business-centric model of American drug pricing, it ...
unnamed file

Testing negative for COVID-19 antibodies? Many people still have some protection against the virus

Rachel Schraer | 
For every person testing positive for antibodies, two [people with negative tests] were found to have specific T-cells which identify ...
dd db a fae a c

The rich get safer? Developing countries likely last in line to get virus vaccine

Christina Larson, Maria Cheng | 
Worldwide, about a dozen potential COVID-19 vaccines are in early stages of testing. While some could move into late-stage testing ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists